Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-09-18
2007-09-18
Hayes, Robert C. (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
Reexamination Certificate
active
10186681
ABSTRACT:
Methods of treating and/or prophylaxis Alzheimer's disease by preventing the formation of cerebral amyloid due to the growth and disruption of dense microspheres (DMS) are disclosed utilizing medicaments that are effective in preventing or inhibiting the growth and disruption of DMS.
REFERENCES:
patent: 4540564 (1985-09-01), Bodor
patent: 4816416 (1989-03-01), Averback
patent: 4919915 (1990-04-01), Averback
patent: 5231170 (1993-07-01), Averback
patent: WO90/09789 (1990-09-01), None
patent: WO95/16917 (1995-06-01), None
Small et al. 2000. Proc Natl Acad Sci USA 97:6037-6042.
Vickers 2002. Drugs Aging 19:487-494.
Cooper et al. 1995. Current Protocols in Immunology 2.4.1-2.4.9.
Finney, “Molecular Cloning of PCR Products,”Current Protocols in Molecular Biology(1987), Ausubel et al., Eds., p. 15.7.1, John Wiley & Sons, New York.
Kono et al., “Is it Useful to Manage Alzheimer's Disease as Two Clinical Subtypes: Early Onset and late Onset Subtypes?,”Basic clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases(1990), vol. 2, pp. 143-146, Plenum Press, New York.
Brandt et al., “Relation of Age of Onset and Duration of Illness to cognitive Functioning in Alzheimer's Disease,”Neuropsychiatry, Neuropsychology, and Behavioral Neurolgy(1989), vol. 2, No.2, pp. 93-101.
Stein et al., “Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review,”Cancer Research(1988), vol. 48, pp. 2659.-2668.
Saiki et al., “Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase,”Science(1988), vol. 239, pp. 487-491.
Hara, “Microscopic Globular Bodies in the Human Brain,”Journal of Neuropathology and Experimental Neurology(1986), vol. 45, No. 2, pp. 169-178.
Knesivich et al., “Aphasia, Family History, and the Longitudinal course of Senile Dementia of the Alzheimer Type,”Psychiatry Res.(1984), vol. 14, pp. 255-263.
Averback, “Dense Microspheres in Normal Human Brain,”Acta Neuropathol.(1983), vol. 61, pp. 148-152.
Tomilinson et al., “Observations on the Brains of Demented Old People,”Journal of Neurological Sciences(1970), vol. 11, pp. 205-242.
Tomilinson et al., “Observations on the Brains of Non-Demented Old People,”Journal of Neurological Sciences(1968), vol. 11, pp. 331-356.
Blessed et al., “The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects,”British Journal of Psychiatry(1968), vol. 114, pp. 797-811.
Paterson et al., “Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation,”Proc. Natl. Acad. Sci. USA(1977), vol. 74, pp. 4370-4374.
Corsellis, “Aging and Dementias,”Greenfield's Neuropatholgy(1976), pp. 796-848, Edward Arnold, London, United Kingdom.
Rojanasakul, “Antisense Oligonucleotide Therapeutics: Drug Delivery and Targeting,”Advanced Drug Delivery Reviews(1996), vol. 18, pp. 115-131.
Gura,Science(1995), vol. 270, pp. 575-577.
Minturn et al.,J. Neurosci.(1995), vol. 15, pp. 6757-6766.
Gaetano et al.,JBC(1997), vol. 272, pp. 12195-12201.
Goshima et al.,Nature(1995), vol. 376, pp. 509-514.
Hawkins et al.,Biochemistry(1993), vol. 32, pp. 9985-9993.
Murakami et al.,Gene(1996), vol. 179, pp. 245-249.
Izzo et al.,Eur. J. Biochem.(1988), vol. 174, pp. 569-578.
Uhlmann et al.,Chem. Rev.(1990), vol. 90, pp. 544-584.
Harding et al.,JBC(1986), pp. 8547-8555.
Hayes Robert C.
Kolker Daniel E.
Nymox Corporation
LandOfFree
Pharmaceutically active agents that impede the formation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active agents that impede the formation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active agents that impede the formation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3768118